APA (7e ed.) Bronvermelding

Moe, M., Micallef, R., Pwint, T., Maughan, T., Mort, D., & Wagstaff, J. (2008). Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer.

Chicago (17e ed.) Bronvermelding

Moe, M., R. Micallef, T. Pwint, T. Maughan, D. Mort, en J. Wagstaff. Cetuximab Plus Irinotecan as Third Line Chemotherapy for Metastatic Colorectal Cancer. 2008.

MLA (9e ed.) Bronvermelding

Moe, M., et al. Cetuximab Plus Irinotecan as Third Line Chemotherapy for Metastatic Colorectal Cancer. 2008.